Aortic infective endocarditis managed by the Ross procedure

Area of Science:

• Cardiovascular Surgery
• Infective Endocarditis
• Prosthetic Valve Development

Background:

• Homografts have shown success in aortic endocarditis treatment.
• Further innovation is needed for improved valve replacement strategies.
• The potential of autografts for enhanced viability and infection resistance is recognized.

Purpose of the Study:

• To evaluate the efficacy of pulmonary autografts in aortic valve replacement for infective endocarditis.
• To assess the clinical outcomes, including infection recurrence and mortality.
• To compare the benefits of pulmonary autografts against existing methods.

Main Methods:

• A cohort of 13 consecutive patients with infective aortic endocarditis underwent aortic valve replacement using pulmonary autografts.
• The autografts were antibiotic-perfused to ensure viability.
• Clinical results and follow-up data were meticulously collected.

Main Results:

• Excellent early clinical results were achieved in all 13 patients.
• Follow-up extending to 30 months demonstrated sustained excellent outcomes.
• Zero re-infection and zero mortality rates were recorded.
• Low rates of thromboembolism and no need for anticoagulation were observed.

Conclusions:

• Pulmonary autograft placement is an effective technique for aortic valve replacement in infective endocarditis.
• This method provides excellent infection cure rates with minimal complications.
• The technique offers advantages such as reduced thromboembolism risk and elimination of anticoagulation requirements.